LifeTech Scientific Corporation Stock
Equities
1302
KYG548721177
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.69 HKD | +0.60% | -2.31% | -28.09% |
Sales 2024 * | 1.47B 204M 1.59B | Sales 2025 * | 1.77B 245M 1.92B | Capitalization | 7.25B 1B 7.82B |
---|---|---|---|---|---|
Net income 2024 * | 328M 45.3M 354M | Net income 2025 * | 399M 55.1M 431M | EV / Sales 2024 * | 4.92 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 4.09 x |
P/E ratio 2024 * |
22.4
x | P/E ratio 2025 * |
17.4
x | Employees | 1,448 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.41% |
1 day | +0.60% | ||
1 week | -2.31% | ||
1 month | -1.74% | ||
3 months | -16.34% | ||
6 months | -29.58% | ||
Current year | -28.09% |
Managers | Title | Age | Since |
---|---|---|---|
Yue Hui Xie
CEO | Chief Executive Officer | 54 | 06-08-16 |
Jian Xiong Liu
DFI | Director of Finance/CFO | 53 | 10-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jian Xiong Liu
DFI | Director of Finance/CFO | 53 | 10-08-31 |
Feng Jiang
BRD | Director/Board Member | 61 | 14-03-31 |
Yue Hui Xie
CEO | Chief Executive Officer | 54 | 06-08-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.16% | 2 M€ | -14.14% | ||
0.02% | 112 M€ | +4.61% | - | |
0.02% | 4 M€ | -4.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.69 | +0.60% | 20,928,000 |
24-05-30 | 1.68 | -0.59% | 6,414,000 |
24-05-29 | 1.69 | -.--% | 15,036,000 |
24-05-28 | 1.69 | -0.59% | 8,296,000 |
24-05-27 | 1.7 | -1.73% | 6,372,000 |
Delayed Quote Hong Kong S.E., May 31, 2024 at 04:08 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.09% | 1B | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- 1302 Stock